CIG (06166) surged over 6% again, reaching HK$87.75 by the time of writing, with a trading volume of HK$79.26 million. The company announced on the evening of December 8 its intention to inject approximately $100 million into its wholly-owned US subsidiary, CIG America, using proceeds from its H-share issuance.

The capital injection will be specifically allocated to expanding high-speed optical module production capacity in North America and Southeast Asia, enhancing overseas R&D scale and technological iteration capabilities, broadening key market and client channels, strategically stockpiling critical components, strengthening supply chain collaboration and security, and supplementing working capital.

CIG stated that this move aligns with the strategic objectives outlined in its H-share prospectus to "bolster R&D investment, expand production capacity, and global market presence." The funding will significantly strengthen CIG America's financial position, reduce its debt-to-asset ratio, enhance synergies with affiliated subsidiaries, and improve global production delivery and supply chain management capabilities.